Article

AIG gives $5 million to ORBIS for blindness prevention

New York-American International group Inc. (AIG) has given a $5 million grant to ORBIS International to sustain and continue the growth of the group's long-term blindness prevention programs in Vietnam, China, India, Bangladesh, Ethiopia, and Latin America.

New York-American International group Inc. (AIG) has given a $5 million grant to ORBIS International to sustain and continue the growth of the group's long-term blindness prevention programs in Vietnam, China, India, Bangladesh, Ethiopia, and Latin America.

Geoffrey Holland, ORBIS international executive director, said the fight against avoidable blindness requires comprehensive, long-term solutions and the country programs will build sustainable eye care infrastructures and services.

According to estimations by the World Health Organization nearly 37 million people worldwide are blind and 124 million people have such poor vision normal life is impossible. The catch is 75% of those people don't have to be blind and that is where ORBIS comes in.

AIG has been a big supporter of ORBIS, being involved with their Flying Eye Hospital and aiding in launching the country programs. The current program will run from October 2007 through September 2012. The partnership was announced at the 25th Anniversary celebration of ORBIS in New York city on March 1st 2007.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.